All Issue

2020 Vol.1, Issue 2

Review article


March 2020. pp. 1-4
Abstract

Sorry, not available.
Click the PDF button.
References
1 

중앙암등록본부. 2017년 암등록통계 보도자료

2 

Catalona WJ et al., Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial, JAMA, 1998

10.1001/jama.279.19.15429605898
3 

Hatakeyama S et al., Recent progress and perspectives on prostate cancer biomarkers, Int J Clin Oncol, 2017

4 

Mikolajczyk SD et al., A truncated precursor form of prostate-specific antigen is a more specific serum marker of prostate cancer, Cancer Res, 2001

5 

Mikolajczyk SD et al., Proenzyme forms of prostate- specific antigen in serum improve the detection of prostate cancer, Clin Chem, 2004

10.1373/clinchem.2003.02682315054080
6 

2014 NCCN Clinical practice Guidelines in Oncology_ Prostate Cancer Early Detection, 2014

7 

2017 NCCN Clinical practice Guidelines in Oncology_ Prostate Cancer Early Detection, 2017

8 

2016 EAU-ESTRO-SIOG Guidelines on Prostate Cancer, 2016

9 

Phi 신의료기술의 안전성 및 유효성 평가결과 고시 (제2017-186호).

10 

Catalona WJ et al., A multi-center study of [-2]ProPSA in combination with PSA and free PSA for prostate cancer detection in the 2 to 10 ng/ml PSA range, J Urol, 2011

11 

Stephen C et al., Multicenter evaluation of [-2]Proprostate -specific antigen and the prostate health index for detecting prostate cancer, Clin Chem, 2013

10.1373/clinchem.2012.19578423213080
12 

Loeb S et al., The prostate health index selectively identifies clinically significant prostate cancer, J Urol, 2015

10.1016/j.juro.2014.10.12125463993PMC4404198
13 

Calle C et al., Multicenter evaluation of the prostate health index to detect aggressive prostate cancer in biopsy naïve men, J Urol, 2015

14 

Loeb S et al., Prostate health index improves multivariable risk prediction of aggressive prostate cancer, BJU Int, 2017

10.1111/bju.1367627743489PMC5392379
15 

Chiu PKF et al., A multicentre evaluation of the role of the prostate health index (PHI) in regions with differing prevalence of prostate cancer: Adjustment of PHI reference ranges is needed for European and Asian settings, Eur Urol, 2019

16 

Park H et al., Diagnostic performance of %[-2]proPSA and prostate health index for prostate cancer: prospective, multi-institutional study, JKMS, 2018

10.3346/jkms.2018.33.e9429495138PMC5835587
Information
  • Publisher :The Association of Korean Urologists
  • Publisher(Ko) :대한비뇨의학과의사회
  • Journal Title :비뇨의학 Urology Digest
  • Volume : 1
  • No :2
  • Pages :1-4